Phospholipase C gamma modulation and uses thereof for management of pain and nociception

Details for Australian Patent Application No. 2005244036 (hide)

Owner Universite De Laval

Inventors De Koninck, Yves; Coull, Jeffrey, A. M.

Agent Cullen & Co

Pub. Number AU-A-2005244036

PCT Pub. Number WO2005/110490

Priority 60/627,174 15.11.04 US; PCT/ CA2004/000726 14.05.04 CA

Filing date 13 May 2005

Wipo publication date 24 November 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110490 Priority application(s): WO2005/110490

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244037-Polymeric coupling agents and pharmaceutically-active polymers made therefrom

2005244031-Method and apparatus for coupling melt conduits in a molding system and/or a runner system